Cargando…

Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process

OBJECTIVES: To evaluate the French cystic fibrosis newborn screening algorithm, based on data tracked by a centralized monitoring process, from 2002 to 2014. The programme aimed to attain European Standards in terms of positive predictive value, sensitivity, the ratio of screen positive patients dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Munck, Anne, Delmas, Dominique, Audrézet, Marie-Pierre, Lemonnier, Lydie, Cheillan, David, Roussey, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813881/ https://www.ncbi.nlm.nih.gov/pubmed/28454512 http://dx.doi.org/10.1177/0969141317692611

Ejemplares similares

Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France
por: Scotet, Virginie, et al.
Publicado: (2012)

Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis
por: Munck, Anne
Publicado: (2020)

First Wave of COVID-19 in French Patients with Cystic Fibrosis
por: Corvol, Harriet, et al.
Publicado: (2020)

Quality of care in cystic fibrosis: assessment protocol of the French QIP PHARE-M
por: Pougheon Bertrand, Dominique, et al.
Publicado: (2018)

Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry
por: Vongthilath, Réchana, et al.
Publicado: (2019)

Newborn Screening for Cystic Fibrosis in Delaware
por: Shenoy, Ambika, et al.
Publicado: (2018)

Cystic fibrosis diagnosed by state newborn screening: Or is it?
por: Fox, Maura, et al.
Publicado: (2020)

Lessons from the on-site quality audit of data transmitted to the French cystic fibrosis registry
por: Pellen, Nadine, et al.
Publicado: (2018)

Cancer incidence and prevalence in cystic fibrosis patients with and without a lung transplant in France
por: Rousset-Jablonski, Christine, et al.
Publicado: (2022)

Communicating cystic fibrosis newborn screening results to parents
por: Seddon, L., et al.
Publicado: (2020)

History of Newborn Screening for Cystic Fibrosis—The Early Years
por: Travert, Georges, et al.
Publicado: (2020)

Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening
por: DeCelie-Germana, Joan Kathleen, et al.
Publicado: (2023)

Glucose tolerance in Canadian and French cystic fibrosis adult patients
por: Reynaud, Quitterie, et al.
Publicado: (2019)

Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients
por: Boëlle, Pierre‐Yves, et al.
Publicado: (2018)

Introduction of a collaborative quality improvement program in the French cystic fibrosis network: the PHARE-M initiative
por: Pougheon Bertrand, Dominique, et al.
Publicado: (2018)

Why Do We Screen Newborn Infants for Cystic Fibrosis?
por: Barben, Jürg, et al.
Publicado: (2020)

A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes
por: Burlina, Alberto, et al.
Publicado: (2022)

Non-Linear Pharmacokinetics of Oral Roscovitine (Seliciclib) in Cystic Fibrosis Patients Chronically Infected with Pseudomonas aeruginosa: A Study on Population Pharmacokinetics with Monte Carlo Simulations
por: Leven, Cyril, et al.
Publicado: (2020)

The Role of Extended CFTR Gene Sequencing in Newborn Screening for Cystic Fibrosis
por: Bergougnoux, Anne, et al.
Publicado: (2020)

Newborn Screening for Cystic Fibrosis in Russia: A Catalyst for Improved Care
por: Sherman, Victoria, et al.
Publicado: (2020)

Factors affecting the growth of infants diagnosed with cystic fibrosis by newborn screening
por: Patterson, K. D., et al.
Publicado: (2019)

Early diagnosis from newborn screening maximises survival in severe cystic fibrosis
por: Tridello, Gloria, et al.
Publicado: (2018)

Newborn Screening for Cystic Fibrosis: Over the Hump, Still Need to Fine-Tune It
por: Castellani, Carlo
Publicado: (2020)

Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis
por: Ooi, Chee Y., et al.
Publicado: (2019)

Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present
por: Botti, Matteo, et al.
Publicado: (2021)

Two Years of Newborn Screening for Cystic Fibrosis in North Macedonia: First Experience
por: Fustik, S, et al.
Publicado: (2021)

Clinical complications in children with false-negative results in cystic fibrosis newborn screening
por: Zybert, Katarzyna, et al.
Publicado: (2021)

Proteome of airway surface liquid and mucus in newborn wildtype and cystic fibrosis piglets
por: Rodriguez-Piñeiro, Ana M., et al.
Publicado: (2023)

Implementing a tracking system for confirmatory diagnostic results after positive newborn screening for cystic fibrosis—implications for process quality and patient care
por: Gramer, Gwendolyn, et al.
Publicado: (2020)

Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California
por: Salinas, Danieli B., et al.
Publicado: (2016)

Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization
por: Hubert, Dominique, et al.
Publicado: (2021)

Early mortality in lung cancer: French prospective multicentre observational study
por: Grivaux, Michel, et al.
Publicado: (2016)

Clinical practice versus guidelines for the screening of cystic fibrosis-related diabetes: A French survey from the 47 centers
por: Weiss, Laurence, et al.
Publicado: (2022)

Is chest CT useful in newborn screened infants with cystic fibrosis at 1 year of age?
por: Thia, Lena P, et al.
Publicado: (2014)

Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis
por: Armstrong, Rachael E., et al.
Publicado: (2020)

Validation of a Custom Next-Generation Sequencing Assay for Cystic Fibrosis Newborn Screening
por: Sicko, Robert J., et al.
Publicado: (2021)

Nationwide lung function monitoring from infancy in newborn-screened children with cystic fibrosis
por: Sandvik, Rikke M., et al.
Publicado: (2023)

Correction to: Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization
por: Hubert, Dominique, et al.
Publicado: (2021)

Surgical treatment of non-cystic fibrosis bronchiectasis in Central Europe
por: Selman, Alaa, et al.
Publicado: (2021)

Flagellin concentrations in expectorations from cystic fibrosis patients
por: Balloy, Viviane, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1fnq7dlp9ju7vr3rmmq6c8l32i